Evaluating the Effectiveness and Safety of Switching from Salmeterol - Fluticasone Inhalation to Formoterol - Budesonide Inhalation as Single Maintenance and Reliever Therapy (SMART) Approach in Partly Controlled or Uncontrolled Asthma Patients

被引:0
|
作者
Khatri, N. [1 ]
Kapoor, S. [2 ]
Arya, N. [3 ]
Bhagat, S. [1 ]
Patil, S. [4 ]
Barkate, H. [1 ]
机构
[1] Glenmark Pharmaceut Ltd, Global Med Affairs, Mumbai, Maharashtra, India
[2] Shivalik Hosp, Chest Med, Faridabad, Punjab, India
[3] Hamidia Hosp, Med, Bhopal, India
[4] Glenmark Pharmaceut Ltd, Global Med Affairs, Mumbai, Maharashtra, India
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A1315
引用
收藏
页数:3
相关论文
共 39 条
  • [21] Evaluation of single maintenance and reliever therapy (SMART) prescribing of budesonide-formoterol for asthma after a clinical pharmacist-led initiative
    Harris, Ila M.
    Philbrick, Ann M.
    Klemenhagen, Kristen C.
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2024, 7 (03): : 215 - 223
  • [22] Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy in Denmark - Cost-effectiveness analysis based on five randomised controlled trials
    Wickstrom, Jannie
    Dam, Nanna
    Malmberg, Irena
    Hansen, Brian Bekker
    Lange, Peter
    CLINICAL RESPIRATORY JOURNAL, 2009, 3 (03): : 169 - 180
  • [23] Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial
    Patel, Mitesh
    Pilcher, Janine
    Pritchard, Alison
    Perrin, Kyle
    Travers, Justin
    Shaw, Dominick
    Holt, Shaun
    Harwood, Matire
    Black, Peter
    Weatherall, Mark
    Beasley, Richard
    LANCET RESPIRATORY MEDICINE, 2013, 1 (01): : 32 - 42
  • [24] Comparison of early effects of budesonide/formoterol maintenance and reliever therapy with fluticasone furoate/vilanterol for asthma patients requiring step-up from inhaled corticosteroid monotherapy
    Hozawa, Soichiro
    Terada, Michikazu
    Haruta, Yoshinori
    Hozawa, Maki
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2016, 37 : 15 - 23
  • [25] Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study
    Cheng, Shih-Lung
    Ho, Ming-Lin
    Lai, Yun-Fa
    Wang, Hao-Chien
    Hsu, Jeng-Yuan
    Liu, Shih-Feng
    Huang, Ming-Shyang
    Lee, Cheng-Hung
    Lin, Ching-Hsiung
    Hang, Liang-Wen
    Liu, Yu-Chih
    Yang, Kuang-Yao
    Wang, Jia-Horng
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 5441 - 5450
  • [26] Safety and Effectiveness of As-Needed Formoterol in Asthma Patients Taking Inhaled Corticosteroid (ICS)-Formoterol or ICS-Salmeterol Maintenance Therapy
    Reddel, Helen Kathryn
    Brusselle, Guy
    Lamarca, Rosa
    Gustafson, Per
    Anderson, Gary P.
    Jorup, Carin
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (07): : 2104 - 2114.e3
  • [27] Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma A Systematic Review and Meta-analysis
    Beasley, Richard
    Harrison, Tim
    Peterson, Stefan
    Gustafson, Per
    Hamblin, Angus
    Bengtsson, Thomas
    Fageras, Malin
    JAMA NETWORK OPEN, 2022, 5 (03)
  • [28] Cost-effectiveness analysis of budesonide/formoterol SMART therapy versus salmeterol/fluticasone plus as-needed SABA among patients ≥12 years with moderate asthma from the Chinese societal perspective
    Zhou, Keruo
    Zhang, Min
    Zuo, Chenyu
    Xie, Xiazhen
    Xuan, Jianwei
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 1018 - 1026
  • [29] Evaluating asthma control in patients using Budesonide/Formoterol FDC as maintenance treatment, with or without reliever, in Greece. Results from the NOTOS study
    Steiropoulos, Paschalis
    Kostikas, Konstantinos
    Leontaridi, Christina
    Angelis, Nikolaos
    Papanastasiou, Polyanthi
    Bertoli, Maria
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [30] COST EFFECTIVENESS OF BUDESONIDE/FORMOTEROL VERSUS FLUTICASONE/SALMETEROL FROM A SWEDISH HEALTH CARE PERSPECTIVE BASED ON REAL-WORLD EFFECTIVENESS AND SAFETY IN PATIENTS WITH COPD
    Hedegaard, M.
    Janson, C.
    Lisspers, K.
    Stallberg, B.
    Johansson, G.
    Jorgensen, L.
    Larsson, K.
    VALUE IN HEALTH, 2013, 16 (03) : A235 - A235